Detection of cancer-specific fusion genes is critical in both research and clinical settings, as it can ensure that the correct diagnosis is made and that the optimal treatment is chosen.
While current methodologies used to detect such fusion genes can be both laborious and time consuming, QuanDx’s Lung Cancer ALK/ROS1/RET Testing Panel provides a sensitive, specific, reliable and cost-effective tool that is easy to perform for the routine screening of lung cancer fusion transcripts.
The QuanDx Lung Cancer Panel utilizes Yin-Yang probes, a novel technology for nucleic acid detection and related applications. The Lung Cancer ALK/ROS1/RET Testing Panel is a novel multiplex reverse transcription real-time PCR (RT-qPCR) system for simultaneous detection of 6 fusion genes, including 35 fusion variants. Fusion and control gene transcripts are co-amplified in each reaction and identified by specific fluorescent probes.
For Research Use Only. Not intended for use in diagnostic procedures.
Product coming soon.
|Fusion genes||KIF5B-RET, KIF5B-ALK, CD74-ROS1, TFG-ALK, SLC34A2-ROS1, EML4-ALK|
|Sample types||FFPE, frozen, and fresh lung cancer tissue|
|Reaction Volume||20 µL|
|Reaction time||2 hours|
|Internal control||GUSB as housekeeping genes|
|Instruments||Compatible with Bio-Rad CFX96, iCycler, ABI7500, Roche Lightcycler 480, Stratagene Mx3000P/Mx3005P, and other commonly used RT- qPCR instruments.|
Lung Cancer ALK/ROS1/RET Testing Panel
Please contact us for a quote or with any questions about our products.